Back to Polls Poll Results

Poll Results


Which insulins do you or your child use?


Vote for all that apply


Short acting insulins


























Other short acting insulin






Long acting insulins
































Other long acting insulin








Premixed (70/30, etc.)






Other insulin






Don't use insulin






Total votes: 901


Which insulins do you or your child use?

Poll dates: January 21 - 28, 2007
Total Votes: 901

Insulin users today have a great variety of products from which to choose. In the past few years, two fast-acting analogs (NovoLog and Humalog) and one long-acting analog (Lantus) have been introduced and have changed the way many people use insulin. The use of Regular insulin among our readers has dropped off to just one percent. NPH use has dropped too, from 32% in 2000 to just 8% in 2006.

This table shows readers' answers to this survey over the past years:

  Answer     Jan 2007     Jan 2006     Jan 2005     Jan 2004     Jan 2003     Jan 2002     Mar 2000  
Short acting insulins
NovoLog 33% 28% 27% 26% 12% 3% --
Humalog 17% 20% 22% 26% 34% 37% 35%
Regular 1% 1% 1% 2% 3% 4% 12%
Apidra 1% 1% 1% -- -- -- --
Long acting insulins
Lantus 31% 32% 27% 21% 17% 11% --
Levemir 4% 2% 1% -- -- -- --
NPH 6% 8% 14% 16% 22% 28% 32%
Lente 1% 1% 1% 1% 1% 3% 4%
Ultralente 1% 1% 1% 1% 2% 5% 7%
Premixed 1% 1% 1% 1% 2% 2% 5%
Other insulin 1% 1% 1% 1% 2% 2% 2%
Percentages based on use compared with all responses

Looking at answers in the short-acting and long-acting insulins shows a dramatic change since 2000. The following graphs illustrate the rapid increase in use of insulin analogs and the concurrent decline in the use of Regular and NPH.

Rapid Acting Insulin Use

The rise in the use of NovoLog has been particularly significant since it was introduced in 2002. Among users of rapid-acting insulin, NovoLog is used by almost two-thirds of our visitors (62%, up from 57% in 2006), while use of Humalog continues to decline (now at 33%, down from 40% in 2006). Apidra, new to the US market in 2006, now has 3% of rapid acting insulin uses. The use of Regular continues to decline.

Graph. Click for larger view.
Data within rapid-acting insulin only illustrating the steady increase in the use of NovoLog

Graph. Click for larger view.
Data for rapid-acting insulin among all responses

Long Acting Insulin Use

As of January 2007, more CWD visitors report using Lantus than any other insulin. This year, almost three-fourths (73%) of people who use long acting insulin report using Lantus, about the same as last year (74%). The use of NPH continues to decline and and now stands at just 16%. Few people use Lente and Ultralente. Levemir, new in 2005, is used by 10%, up from 6% last year. Given the clinical benefits of using Lantus or Levemir over NPH, it's no surprise to see the rapid decline in use of NPH. (See our page about Care Suggestions for citations to studies about NPH.)

Graph. Click for larger view.
Data for long-acting insulin only showing the continuing decline in the use of NPH insulin

Graph. Click for larger view.
Data for long-acting insulin among all responses

[Download an Excel spreadsheet with the data and graphs from this poll]

[Return to the current poll]

  Back to Polls Return to the Top of This Page

Last Updated: Sunday February 04, 2007 12:36:06
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.